Moderna's second-generation COVID-19 vaccine is currently under review for emergency use authorization (EUA) and could be delivered to Taiwan as early as September, the Central Epidemic Command Center (CECC) said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Eastern Taiwan drill simulates magnitude 7.3 earthquake
09/17/2026 08:56 PM - Politics
MAC plays down Taipei-Shanghai forum after entry-permit criticism
09/17/2026 08:17 PM - Business
Central bank keeps rates unchanged for economic stability amid turmoil
09/17/2026 07:42 PM - Society
Health tokens redeemable from December: Health ministry
09/17/2026 07:30 PM - Society
Kaohsiung man arrested in stabbing of bedridden grandmother
09/17/2026 07:17 PM